AnaptysBio, Inc.
ANAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15 | -$39 | -$39 | -$22 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $9 | $9 | $8 |
| Change in WC | -$74 | -$29 | $2 | -$69 |
| Other Non-Cash | $31 | $18 | $16 | $15 |
| Operating Cash Flow | -$27 | -$40 | -$11 | -$67 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$20 | -$54 | -$123 | -$121 |
| Inv. Sales/Matur. | $123 | $91 | $137 | $92 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $103 | $36 | $15 | -$29 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | $0 | $0 |
| Stock Issued | $0 | $1 | $0 | $1 |
| Stock Repurch. | -$10 | -$51 | -$4 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$24 | $27 |
| Financing Cash Flow | -$10 | -$50 | -$29 | $28 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $66 | -$54 | -$24 | -$69 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $99 | $123 | $192 |
| End Cash | $110 | $44 | $99 | $123 |
| Free Cash Flow | -$27 | -$40 | -$11 | -$67 |